Display options
Cite
Hauffa BP, Touraine P, Urquhart-Kelly T, et al. Managing Transition in Patients Treated with Growth Hormone. Front Endocrinol (Lausanne). 2017;8:346doi: 10.3389/fendo.2017.00346.
Hauffa, B. P., Touraine, P., Urquhart-Kelly, T., & Koledova, E. (2017). Managing Transition in Patients Treated with Growth Hormone. Frontiers in endocrinology, 8346. https://doi.org/10.3389/fendo.2017.00346
Hauffa, Berthold P, et al. "Managing Transition in Patients Treated with Growth Hormone." Frontiers in endocrinology vol. 8 (2017): 346. doi: https://doi.org/10.3389/fendo.2017.00346
Hauffa BP, Touraine P, Urquhart-Kelly T, Koledova E. Managing Transition in Patients Treated with Growth Hormone. Front Endocrinol (Lausanne). 2017 Dec 11;8:346. doi: 10.3389/fendo.2017.00346. eCollection 2017. PMID: 29312142; PMCID: PMC5732460.
Copy Download .nbib Format: NLM
Share it on

Front Endocrinol (Lausanne). 2017 Dec 11;8:346. doi: 10.3389/fendo.2017.00346. eCollection 2017.

Managing Transition in Patients Treated with Growth Hormone.

Frontiers in endocrinology

Berthold P Hauffa, Philippe Touraine, Tanya Urquhart-Kelly, Ekaterina Koledova

Affiliations

  1. Department of Pediatric Endocrinology, University of Duisburg-Essen, Essen, Germany.
  2. Department of Endocrinology and Reproductive Medicine, Centre des Maladies Endocriniennes Rares de la Croissance et du Développement, Paris, France.
  3. Department of Nursing and Midwifery, Sheffield Hallam University, Sheffield, United Kingdom.
  4. Global Medical Affairs, Merck KGaA, Darmstadt, Germany.

PMID: 29312142 PMCID: PMC5732460 DOI: 10.3389/fendo.2017.00346

Abstract

Growth hormone (GH) promotes growth in children, but is also essential for bone strength, body composition, metabolic factors, such as lipid profile, and maintenance of quality of life. The Merck KGaA (Germany) funded "360° GH in Europe" meeting, held in Lisbon, Portugal, in June 2016, comprised three sessions entitled "

Keywords: adolescent; endocrinology; growth hormone deficiency; pediatric; personalized medicine; transition

References

  1. Int J Pediatr Endocrinol. 2016;2016:6 - PubMed
  2. Curr Biol. 2016 May 23;26(10 ):R432-43 - PubMed
  3. J Clin Endocrinol Metab. 2011 Jun;96(6):1587-609 - PubMed
  4. J Clin Endocrinol Metab. 1997 Feb;82(2):352-6 - PubMed
  5. Helv Paediatr Acta Suppl. 1989 Jun;52:1-125 - PubMed
  6. Bone. 2010 Feb;46(2):336-41 - PubMed
  7. Horm Res Paediatr. 2013;79(2):51-67 - PubMed
  8. J R Soc Med. 2001;94 Suppl 40:2-4 - PubMed
  9. Am J Physiol Endocrinol Metab. 2001 Dec;281(6):E1191-6 - PubMed
  10. Horm Res Paediatr. 2012;78(4):247-55 - PubMed
  11. Eur J Endocrinol. 2005 Feb;152(2):165-70 - PubMed
  12. J Adolesc Health. 2003 Oct;33(4):309-11 - PubMed
  13. J Clin Endocrinol Metab. 2010 Nov;95(11):5110-21 - PubMed
  14. J Pediatr Endocrinol Metab. 2012;25(1-2):97-105 - PubMed
  15. Dtsch Med Wochenschr. 2009 Dec;134(50):2551-5 - PubMed
  16. Eur J Endocrinol. 2007 Dec;157(6):695-700 - PubMed
  17. Front Endocrinol (Lausanne). 2017 Nov 20;8:313 - PubMed
  18. Paediatr Child Health. 2007 Nov;12(9):785-93 - PubMed
  19. Front Endocrinol (Lausanne). 2013 Mar 20;4:34 - PubMed
  20. Minerva Endocrinol. 2015 Mar;40(1):23-35 - PubMed
  21. Child Care Health Dev. 2011 Nov;37(6):815-20 - PubMed
  22. J Clin Endocrinol Metab. 2004 Oct;89(10):4857-62 - PubMed
  23. J Endocrinol Invest. 2015 Mar;38(3):377-82 - PubMed
  24. Eur J Endocrinol. 2000 Sep;143(3):347-52 - PubMed
  25. Arch Dis Child Educ Pract Ed. 2015 Dec;100(6):313-20 - PubMed
  26. Presse Med. 2016 May;45(5):e119-29 - PubMed
  27. Eur J Endocrinol. 2013 Oct 01;169(5):587-96 - PubMed
  28. Endocr Connect. 2016 Nov;5(6):R44-R54 - PubMed

Publication Types